Legend Biotech Corporation
LEGN
$34.86
$1.374.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.14B | 1.03B | 914.98M | 802.59M | 731.64M |
| Total Other Revenue | -90.00K | 0.00 | -5.92M | -5.66M | -3.24M |
| Total Revenue | 1.14B | 1.03B | 908.97M | 796.84M | 728.31M |
| Cost of Revenue | 911.13M | 822.73M | 776.28M | 698.81M | 665.60M |
| Gross Profit | 227.73M | 206.03M | 132.69M | 98.03M | 62.71M |
| SG&A Expenses | 359.27M | 341.67M | 323.64M | 315.88M | 300.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.20M | 2.00M | 1.00M | 1.00M | 1.00M |
| Total Operating Expenses | 1.27B | 1.17B | 1.10B | 1.02B | 967.25M |
| Operating Income | -135.74M | -137.64M | -191.94M | -218.85M | -238.94M |
| Income Before Tax | -236.57M | -282.67M | -222.53M | -304.34M | -197.51M |
| Income Tax Expenses | 13.61M | 14.21M | 17.23M | 21.05M | 20.70M |
| Earnings from Continuing Operations | -250.18 | -296.88 | -239.76 | -325.39 | -218.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -250.18M | -296.88M | -239.76M | -325.39M | -218.21M |
| EBIT | -135.74M | -137.64M | -191.94M | -218.85M | -238.94M |
| EBITDA | -126.35M | -128.35M | -182.60M | -210.29M | -229.62M |
| EPS Basic | -2.71 | -3.22 | -2.60 | -3.54 | -2.38 |
| Normalized Basic EPS | -0.80 | -0.96 | -0.74 | -1.02 | -0.66 |
| EPS Diluted | -2.76 | -3.26 | -2.61 | -3.54 | -2.38 |
| Normalized Diluted EPS | -0.80 | -0.96 | -0.75 | -1.03 | -0.67 |
| Average Basic Shares Outstanding | 738.61M | 737.26M | 735.85M | 734.49M | 732.96M |
| Average Diluted Shares Outstanding | 369.30M | 368.63M | 376.96M | 376.29M | 375.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |